Polomar Health ServicesPMHS 34 Receivables Turnover is 7.51 as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 34/100 and a GF Value™ of $12.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Polomar Health Services ranks better than 86.74% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Polomar Health Services's Revenue for the
three
months ended in Mar. 2026 was $1.01 Mil. Polomar Health Services's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.13 Mil.
Hence, Polomar Health Services's Receivables Turnover for the
three
months ended in Mar. 2026 was 7.51.
Polomar Health Services (OTCPK:PMHS) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Polomar Health Services Receivables Turnover Related Terms
Polomar Health Services Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Polomar Health Services's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services Receivables Turnover Chart
PMHS vs DHTI, RDGT, BLMH: Receivables Turnover Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a Receivables Turnover of 7.51 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #87 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 13.3%.
Is Polomar Health Services' Receivables Turnover too high?
Polomar Health Services' current Receivables Turnover is 7.51. The Healthcare Providers & Services industry median Receivables Turnover is 7.69. Polomar Health Services' value of 7.51 is 2.3% below this industry median. Based on the distribution chart, Polomar Health Services ranks #87 out of 656 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Polomar Health Services has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' Receivables Turnover compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #87 out of 656 companies for Receivables Turnover. This places Polomar Health Services in the top 13% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.69. Polomar Health Services' value of 7.51 is 2.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.69, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polomar Health Services's current Receivables Turnover of 7.51 is 2.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Receivables Turnover is 7.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.43, compared to a current price of $0.12 — trading 99.1% below its estimated fair value. The current Receivables Turnover is 7.51 and 2.3% below the Healthcare Providers & Services industry median of 7.69. Polomar Health Services' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Receivables Turnover is 7.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.12 is trading 99.1% below its estimated GF Value™ of $12.43.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
Receivables Turnover: 7.51
GF Value™: $12.43 vs. price of $0.12 (99.1% below fair value)
Industry Position: 2.3% below the Healthcare Providers & Services median (#87 of 656)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
34GF Score
Get the complete analysis for PMHS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
